Eli Lilly and Co

LLYNYSE
$1149.36
-10.24-0.88%
At close: Sep 4, 5:00 PM EST
$1149.00
-0.36-0.03%
After Hours: 4:42 PM EST
M&A: Merida Biosciences, Inc. announced it will be acquired by Eli Lilly (LLY) on Monday, August 31, 2026 for $2.9B paid in cash

Eli Lilly Analyst Price Targets

Wall Street analyst price targets and consensus rating for Eli Lilly (LLY).

Price Target Range — 9 Quarters

Analyst Consensus — 20 Analysts

19Buy
1Hold
Consensus RatingBuy# Analysts20Avg. Consensus PT$1237Upside to Avg. PT+7.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings
DateFirmAnalystActionRating ChangePrice Target
Aug 7, 2026Truist SecuritiesRobyn KarnauskasPT RaiseBuy$1370$1376
Aug 6, 2026Wells FargoMohit BansalPT RaiseOverweight$1280$1330